
5 Zacks experts were commissioned to each select his or her single favorite stock with the best chance to gain +100% or more in the months ahead.
Today, you can see these promising picks for just $1.
While we can't guarantee future success, earlier versions of this report have racked up some huge gains. For example, Rolls-Royce soared +116%, Vertiv climbed +171%, and Hims & Hers Health surged +209%.¹
All of them start off with strong Zacks Ranks, meaning that earnings estimates are already on the upswing. This is a key predictor of outperformance over the next 1 to 3 months.
What could be better than stocks that not only climb high but start fast?
No guarantees of course, but the earlier you get aboard these tickers the greater the likelihood of maximizing your profit potential.
Stock #1: The AI Orchestration Pioneer Ready to Explode
Investors should take note of this enterprise automation leader, which has transformed into a complete AI platform that orchestrates humans, robots, and AI agents. With partnerships with major companies, the company is hitting its stride, posting 25% cloud revenue growth and expanding margins. This Zacks Rank #1 (Strong Buy) could easily double as enterprises race to adopt AI automation.
Stock #2: The Hidden Infrastructure Play Powering AI's Energy Revolution
This solar infrastructure specialist manufactures the critical components that connect massive solar farms to the grid, just in time as AI data centers are projected to double their electricity needs by 2030. With its plug-and-play systems deployed globally, this company enables solar deployment in 18-24 months versus a decade for nuclear alternatives.
Stock #3: Wellness Disruptor in Beverage Space Claims Its Crown
This beverage company captured significant market share by targeting health-conscious consumers, with its latest quarter showing 80% sales growth. Backed by a powerhouse distribution partnership with a beverage titan and strategic acquisitions, the company's portfolio now exceeds $4 billion in retail sales.
Stock #4: The Gold Mining Titan Cashing In on Historic Prices
This multi-billion-dollar mining giant with millions of ounces of reserves is perfectly positioned as gold breaks above $4,000. Earnings surged 60% this year. And massive cash flows are funding a significant buyback program while production costs remain far below gold prices.
Stock #5: Little-Known Biotech Company Trading at Bargain Prices
Generating more than half a billion dollars in revenue last year, this biotech company boasts patent protection through 2037 and a potential billion-dollar kidney treatment that has been overlooked by most analysts. Forecasts call for 123% profit growth next year and share price may increase even more.
For the next 30 days, you are invited to look inside portfolios like our Stocks Under $10, Value Investor, and big-swinging Home Run Investor. You can also use Zacks Premium to find and evaluate your own stocks, ETFs, and mutual funds. During your trial, you can sample:
No obligation beyond $1.
You may cancel at any time.
All of our portfolios — from value and growth, to stable income and ETFs — — from value to growth, from stable income to ETFs — are grounded in Zacks Rank fundamentals.
This unbiased, mathematical system has more than doubled the S&P 500's average yearly gain. Even through three recessions and many corrections, it has averaged +23.8% per year.
Let's suppose you had invested $10,000 in the S&P 500 in 1988. You would have more than $500,000 today.
But if you had put that same $10,000 into the Zacks Rank system, with rebalancing at each period and not counting fees, it could have compounded to more than $26.2 million dollars.
While not all picks can be winners, every service was designed to identify recommendations with the highest probability of success.
Here are some past winners:¹
In this Special Report, five Zacks experts each recommend their single favorite stock predicted to increase +100% and more in the next 12 months. This is a must-read report for long-term investors.
Valued at $99, it is yours free when you start your 30-day trial.
Questions? Call toll-free at 1.888.775.8348 M-F, 9 am - 6 pm ET. Outside the U.S., 1.312.265.9309.
+Or click here for Frequently Asked Questions about this Zacks Investor Collection opportunity.
What happens after my 30-day Zacks Investor Collection trial is over?
You'll be notified at least seven days before your trial ends. You can choose to:
Are there money-back guarantees?
You are backed with two assurances. The first is a Guarantee of Satisfaction. You may cancel up to 90 days after your trial is over and if the service has not exceeded your expectations, then your money will be refunded - including the you paid for the trial.
You will also be protected by a full-year, money-back Performance Guarantee. Details. That means if we don't help you beat the marker, we'll refund your subscription.
What portfolios are included in Zacks Investor Collection?
You gain real-time access to buys, sells, and market commentary from all of these private services:
Will following all Zacks long-term portfolio recommendations be hard work or "too much information?"
Not at all - most members start by quickly scanning each of the portfolios, and then simply narrow them down to the one(s) that suit them best.
Also, each day you receive a summary email that spotlights intraday trades and key market commentary from the various services.
And if you have any questions or need any help sorting out which portfolios are best for you, just pick up the phone and talk to a real person who can give you the info you need.
Don't miss this opportunity to discover the impact that the Zacks Rank can have on your portfolio.
It only costs $1. And not 1 cent of further obligation.